| __timestamp | ACADIA Pharmaceuticals Inc. | TG Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 31354781 |
| Thursday, January 1, 2015 | 73869000 | 43445817 |
| Friday, January 1, 2016 | 99284000 | 66489820 |
| Sunday, January 1, 2017 | 149189000 | 96886134 |
| Monday, January 1, 2018 | 187163000 | 153793000 |
| Tuesday, January 1, 2019 | 240385000 | 148369000 |
| Wednesday, January 1, 2020 | 319130000 | 151934000 |
| Friday, January 1, 2021 | 239415000 | 198532000 |
| Saturday, January 1, 2022 | 361575000 | 112128000 |
| Sunday, January 1, 2023 | 351619000 | 76192000 |
Unleashing insights
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Over the past decade, ACADIA Pharmaceuticals and TG Therapeutics have demonstrated distinct strategies in their R&D investments. From 2014 to 2023, ACADIA Pharmaceuticals consistently outpaced TG Therapeutics, with R&D expenses peaking at approximately 360% higher in 2022 compared to 2014. This robust investment reflects ACADIA's aggressive pursuit of new therapies. Meanwhile, TG Therapeutics showed a steady increase, with a notable 150% rise in R&D spending over the same period, highlighting their strategic focus on targeted innovation. The data underscores the dynamic nature of the biotech sector, where strategic R&D investments can significantly influence a company's trajectory and market position.
Comparing Innovation Spending: Eli Lilly and Company and TG Therapeutics, Inc.
Research and Development: Comparing Key Metrics for Novo Nordisk A/S and TG Therapeutics, Inc.
Amgen Inc. or ACADIA Pharmaceuticals Inc.: Who Invests More in Innovation?
Research and Development: Comparing Key Metrics for Takeda Pharmaceutical Company Limited and TG Therapeutics, Inc.
R&D Spending Showdown: Genmab A/S vs TG Therapeutics, Inc.
BioMarin Pharmaceutical Inc. vs TG Therapeutics, Inc.: Strategic Focus on R&D Spending
Who Prioritizes Innovation? R&D Spending Compared for Exelixis, Inc. and ACADIA Pharmaceuticals Inc.
Research and Development: Comparing Key Metrics for Axsome Therapeutics, Inc. and TG Therapeutics, Inc.
TG Therapeutics, Inc. vs Catalyst Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
R&D Insights: How ACADIA Pharmaceuticals Inc. and Arrowhead Pharmaceuticals, Inc. Allocate Funds
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
ACADIA Pharmaceuticals Inc. vs Galapagos NV: Strategic Focus on R&D Spending